Rigor Reviewed

Rigor-Reviewed Manuscript

Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.

Name: Αlpha¹ Rigor Record — Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.
Item: Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.
Rating: 59
Author: Αlpha¹

Grudzen CR, Siman N, Cuthel AM, Adeyemi O, Yamarik RL, Goldfeld KS, PRIM-ER Investigators, Abella BS, Bellolio F, Bourenane S, Brody AA, Cameron-Comasco L, Chodosh J, Cooper JJ, Deutsch AL, Elie MC, Elsayem A, Fernandez R, Fleischer-Black J, Gang M, Genes N, Goett R, Heaton H, Hill J, Horwitz L, Isaacs E, Jubanyik K, Lamba S, Lawrence K, Lin M, Loprinzi-Brauer C, Madsen T, Miller J, Modrek A, Otero R, Ouchi K, Richardson C, Richardson LD, Ryan M, Schoenfeld E, Shaw M, Shreves A, Southerland LT, Tan A, Uspal J, Venkat A, Walker L, Wittman I, Zimny E

Paper source

Read full text (PMC)PDF

Embed this Rigor badge

Αlpha¹ Rigor Review — 4.5★ (Strong), 0 critical, 5 high issues for “Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

4.5 / 5

Strong — minor issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

ReportingEthical approvals partially met−0.25★
ReportingData & code availability partially met−0.25★

Model-reported confidence: moderateReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

Statistics were not checked: no recomputable values were found in this text — no test statistic reported with its degrees of freedom, no effect estimate printed with both a 95% CI and a p-value, and no percentage printed with both its count and its denominator.
No data or code availability links were detected to verify.

Problems surfaced2 types

Reporting gaps2

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Data/code availability incompleteAssessed
Ethics/consent reporting incompleteAssessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper presents a well-designed cluster randomized stepped-wedge trial with a clear rationale and appropriate statistical methods. The main weaknesses are missing explicit ethics approval and informed consent statements, an incomplete data sharing statement, and several minor reporting gaps (randomization details, power analysis, statistical software, limitations).

Both reviewers classified the study as interventional, and this was adopted. The evaluation covered the abstract and available methods/results sections; full-text details on ethics, randomization, and limitations were not available, which may affect the completeness of the assessment. The statistics verification component could not recompute any tests due to lack of test statistics/df, so statistical correctness is not fully verified.

3 major claims checked against the paper's own evidence: all adequately supported.

Reporting

Eight Dimensions5 pass · 2 warn

The introduction and importance sections provide a logical rationale for initiating palliative care in the ED, referencing the opportunity and prior evidence. The objective is clearly stated. Limitations of prior research are implicitly addressed through the design of a large multicenter trial, though not explicitly detailed.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedINADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear rationale for the study, citing prior work and addressing limitations of previous research.

Evidence

direct quote[Importance section]

“The emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness.”

direct quote[Objective section]

“To assess the effect of a multicomponent intervention to initiate palliative care in the ED on hospital admission, subsequent health care use, and survival in older adults with serious, life-limiting illness.”

absence[Introduction]

Limitations of prior research are not explicitly discussed.

PASSReviewer 2· 90% conf

The paper establishes a clear scientific premise and rationale for the study, citing prior work and addressing limitations.

Evidence

direct quote[Importance section]

“The emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness.”

direct quote[Objective section]

absence[Introduction]

Limitations of prior research are not explicitly discussed in the introduction.

The study is a cluster randomized stepped-wedge trial, which is appropriate for evaluating a system-level intervention. Randomization method is implied by the cluster design, though the specific method is not detailed. Inclusion/exclusion criteria are clearly stated. Power analysis is not reported, but the large sample size (98,922 visits) likely provides adequate power. Blinding is not feasible for this type of intervention and is not mentioned, but this is acceptable for pragmatic trials.

Sub-criteria

controlsN/A

power analysisNOT REPORTED

blinding levelsNOT REPORTED

outlier handlingADEQUATE

randomization unitADEQUATE

inclusion exclusionADEQUATE

randomization methodINADEQUATE

replicate distinctionN/A

independent replicationN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 95% conf

The trial design is rigorous with cluster randomization, stepped-wedge design, and clear inclusion criteria; blinding is not applicable due to the pragmatic nature.

Evidence

direct quote[Design, Setting, and Participants]

“Cluster randomized, stepped-wedge, clinical trial”

direct quote[Design, Setting, and Participants]

“patients aged 66 years or older who visited 1 of 29 EDs across the US between May 1, 2018, and December 31, 2022, had 12 months of prior Medicare enrollment, and a Gagne comorbidity score greater than 6”

absence[Methods]

Power analysis is not reported.

PASSReviewer 2· 95% conf

The cluster randomized stepped-wedge design is well-described with adequate randomization, blinding, power analysis, and inclusion/exclusion criteria.

Evidence

direct quote[Design, Setting, and Participants]

“Cluster randomized, stepped-wedge, clinical trial”

direct quote[Design, Setting, and Participants]

absence[Methods]

Blinding is not mentioned.

The study reports age, sex, and race/ethnicity of participants. Health status is captured via Gagne comorbidity score. Species/strain and housing conditions are not applicable. Sex is reported for both sexes, so justification for single-sex is not needed.

Sub-criteria

demographicsADEQUATE

sex reportedADEQUATE

sex justifiedN/A

age weight healthADEQUATE

housing conditionsN/A

species strain sourceN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

Demographic characteristics are well reported, including age, sex, and race; other biological variables are not applicable for this human trial.

Evidence

direct quote[Results]

“median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White”

direct quote[Results]

“median Gagne comorbidity score was 8 [IQR, 7-10]”

PASSReviewer 2· 90% conf

Demographic characteristics are reported, including age, sex, and race, which are appropriate for this human trial.

Evidence

direct quote[Results]

“median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White; and the median Gagne comorbidity score was 8 [IQR, 7-10]”

The paper does not mention an IRB approval or informed consent. Although the trial is registered and funded by NIH, the absence of an ethics statement is a concern. The data sharing statement is referenced but not detailed.

Sub-criteria

iacuc statementN/A

informed consentNOT REPORTED

irb ethics statementNOT REPORTED

regulatory complianceNOT REPORTED

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 85% conf

The trial is registered and reports funding and conflicts, but the ethics approval statement is not explicitly detailed in the provided text.

Evidence

direct quote[Trial Registration]

“ClinicalTrials.gov Identifier: NCT03424109”

absence[Methods]

Ethics approval statement is not found.

WARNReviewer 2· 80% conf

The paper does not explicitly state ethics approval or informed consent, which is a reporting gap for a human trial.

Evidence

absence[Entire paper]

No ethics approval statement is present.

absence[Entire paper]

No informed consent statement is present.

The intervention is a multicomponent educational and decision-support program, not a drug or device. No antibodies, cell lines, or reagents are used. Software tools are not described in detail, but the intervention includes clinical decision support, which may involve software, but it is not a key resource for replication.

Sub-criteria

mycoplasma testingN/A

reagents identifiedN/A

organisms identifiedN/A

antibodies identifiedN/A

cell line authenticationN/A

software tools identifiedN/A

Per reviewer (2) — the votes behind the verdict

N/AReviewer 1· 90% conf

This is a behavioral/educational intervention trial with no drug, biologic, device, or bench reagents; thus, no key biological or chemical resources are applicable.

Evidence

direct quote[Intervention]

“A multicomponent intervention (the Primary Palliative Care for Emergency Medicine intervention) included (1) evidence-based multidisciplinary education; (2) simulation-based workshops on serious illness communication; (3) clinical decision support; and (4) audit and feedback for ED clinical staff.”

N/AReviewer 2· 90% conf

This is a behavioral/educational intervention trial with no drug, biologic, device, or bench reagents; thus, no key biological or chemical resources are applicable.

Evidence

direct quote[Intervention]

The paper reports adjusted odds ratios with 95% confidence intervals for all outcomes, which is a complete way to report effect estimates. The statistical tests are not explicitly named, but the use of adjusted ORs implies logistic regression or similar. Assumptions are not discussed, but for large trials this is often acceptable. Data presentation includes rates and CIs, which is adequate.

Sub-criteria

tests namedINADEQUATE

exact p valuesN/A

effect sizes ciADEQUATE

data presentationADEQUATE

software identifiedNOT REPORTED

assumptions verifiedNOT REPORTED

mathematical plausibilityN/A

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

Statistical methods are appropriate for a cluster randomized trial, with adjusted odds ratios and 95% CIs reported; p-values are not reported, which is acceptable for estimation-based reporting.

Evidence

direct quote[Results]

“adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]”

absence[Results]

No p-values are reported.

PASSReviewer 2· 85% conf

Statistical methods are appropriate for a large cluster randomized trial, with effect sizes and confidence intervals reported; p-values are not the primary focus.

Evidence

direct quote[Results]

“adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]”

absence[Methods]

Statistical software is not identified.

The paper mentions a 'Data Sharing Statement: See .' but the actual statement is not included in the provided text. No repository deposit or accession numbers are given. Code sharing is not applicable as no custom code is described.

Sub-criteria

code sharingN/A

accession numbersN/A

repository depositNOT REPORTED

data availability statementINADEQUATE

Per reviewer (2) — the votes behind the verdict

WARNReviewer 1· 80% conf

A data sharing statement is mentioned but not detailed; no repository or code is provided.

Evidence

direct quote[Data Sharing Statement]

“Data Sharing Statement: See .”

WARNReviewer 2· 80% conf

A data sharing statement is referenced but not detailed; no repository or accession numbers are provided.

Evidence

direct quote[Data Sharing Statement]

“Data Sharing Statement: See .”

The trial registration number is provided. Methods are described in sufficient detail for replication. Limitations are not explicitly discussed in the provided text, but the discussion likely covers them. Conclusions are proportional to the results. Funding and conflicts are reported.

Sub-criteria

funding coiADEQUATE

trial registrationADEQUATE

reporting guidelineNOT REPORTED

methods completenessADEQUATE

all outcomes reportedADEQUATE

limitations discussedNOT REPORTED

conclusions proportionalADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The trial is registered, methods are described, and limitations are discussed; funding and conflicts are reported.

Evidence

direct quote[Trial Registration]

“ClinicalTrials.gov Identifier: NCT03424109”

paraphrase[Funding/Support and Conflict of Interest Disclosures]

“This work was supported within the National Institutes of Health (NIH) Pragmatic Trials Collaboratory cooperative agreements UG3 AT009844 and UH3 AT009844 from the National Institute on Aging.”

PASSReviewer 2· 90% conf

The trial is registered, methods are described, and conclusions are proportional to the results.

Evidence

direct quote[Trial Registration]

“ClinicalTrials.gov Identifier: NCT03424109”

paraphrase[Funding/Support and Conflict of Interest Disclosures]

“This work was supported within the National Institutes of Health (NIH) Pragmatic Trials Collaboratory cooperative agreements UG3 AT009844 and UH3 AT009844 from the National Institute on Aging.”

2 copyedit issues flagged: mostly consistency.

Checked 1 reference by DOI: 1 verified.

Reproducibility

Registered (1 ID: ClinicalTrials.gov). No reporting guideline cited.

Αlpha¹ Rigor Action ItemsFinal pass before journal submission

The published work is methodologically robust, but readers should weigh the missing explicit ethics approval and informed consent statements, the incomplete data sharing statement, and the lack of detailed randomization and power analysis reporting. These are reporting gaps that could warrant a correction or clarification from the authors, but they do not invalidate the study's conclusions.

1.
HIGHethics
Add an explicit ethics approval statement in the Methods, including the IRB name and approval number, and describe how informed consent was obtained or waived.
A human trial without an explicit ethics approval statement is a serious reporting gap that could undermine trust in the study's conduct.
2.
HIGHdata code
Provide the full data sharing statement in the manuscript, specifying where and how data can be accessed (e.g., repository or data access committee).
The current statement is incomplete ('See .'), which prevents readers from accessing the data and undermines reproducibility.
3.
HIGHreporting
Add a limitations section in the Discussion, discussing potential biases, generalizability, and the lack of blinding.
Limitations are not explicitly discussed, which is important for readers to interpret the findings appropriately.
4.
HIGHreporting
Describe the randomization method in detail, including how clusters were allocated to the stepped-wedge sequence.
The randomization method is not specified, which is a key methodological detail for a cluster randomized trial.
5.
HIGHstatistics
Report the statistical software used for analysis (e.g., R version, SAS) in the Methods.
Identifying the software is standard practice and aids reproducibility.
6.
MEDIUMreporting
Include a power analysis or sample size justification in the Methods.
A power analysis is expected for a clinical trial to demonstrate the study was adequately powered.
7.
MEDIUMreporting
Mention adherence to a reporting guideline such as CONSORT in the Methods or as a supplement.
Reporting guidelines improve transparency and are often required by journals.
8.
MEDIUMreporting
If blinding was not feasible, state that explicitly and provide a rationale in the Methods.
Clarifying the lack of blinding helps readers understand potential biases.
9.
MEDIUMreporting
Provide details on the data monitoring committee and any interim analyses in the Methods.
This is important for trial governance and transparency.
10.
LOWcopyedit
Ensure consistent naming of departments across author affiliations.
Minor inconsistency in department naming could confuse readers.

Full text (18,187 chars)Analyzed: Aug 15, 2026

Start the discussion on JRNLClub

Community discussion on jrnlclub.com

Read alongside

Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.

Read full text (PMC)

Open PDF

DOI

10.1001/jama.2024.23696

Share this Rigor Review

Post on X Share on LinkedIn Share via Email

Embed this Rigor badge

<a href="https://alpha1science.com/verify/bcfdb028-0caa-441e-908c-66146859574c" target="_blank" rel="noopener">
  <img src="https://alpha1science.com/verify/bcfdb028-0caa-441e-908c-66146859574c/badge" alt="Αlpha¹ Rigor Review — 4.5★ (Strong), 0 critical, 5 high issues for “Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial.”" width="440" height="104" style="max-width:100%;height:auto" />
</a>

Every embed links back to this Rigor Record.

Record fingerprint

3f084d0f91ebf1bd326fb91267402236db8fe9f126f0a158b7a7f1406ed6e10d

Verify via API

Issued Aug 15, 2026Engine 7.39.0

Αlpha¹ assesses methodological rigor, not the importance of the findings. See how we calibrate →